UPMC is using AI model for breast cancer sentinel node biopsies

Researchers at the UPMC Hillman Cancer Center used UPMC-owned Realyze Intelligence Technology to understand the utility of sentinel lymph node biopsy, or SLNB, for early-stage breast cancer patients under age 70.   
WHY IT MATTERS
The team, led by Dr. Emilia Diego, division chief of breast…

From: www.healthcareitnews.com – Read more